Full Text View
Tabular View
No Study Results Posted
Related Studies
Arsenic Trioxide and Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia (CML)
This study is currently recruiting participants.
Verified March 2014 by Dana-Farber Cancer Institute
Study NCT01397734   Information provided by Dana-Farber Cancer Institute

First Received on July 18, 2011.   Last Updated on March 24, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
More general drug interventions related to this trial
Sponsors listed in this trial